Mattea Abou Faiçal from the University of Ottawa interviews Dr. Marisa Azad. Dr. Marisa Azad is an Associate Clinical Scientist at the Ottawa Hospital Research Institute, and a Mayo Clinic Research Collaborator. She is also an Assistant Professor of Medicine in the Division of Infectious Diseases at The Ottawa Hospital. In this episode, Dr. Marisa Azad shares her research on phage therapy and how her team delivered Canada’s first treatment for a multidrug-resistant joint infection.Learn more: https://www.uottawa.ca/faculty-medicine/directory/dr-marisa-azad0:04 | BEaTS and host introduction.1:11 | Introduction to Dr. Azad.1:45 | Why are periprosthetic joint infections so difficult to treat?3:30 | Introduction to phages, phage therapy, and a landmark Canadian case study6:26 | Finding the right phage: collaboration between Cytophage Technologies and The Ottawa Hospital9:45 | Ethical and regulatory hurdles12:00 | The growing potential of phage therapy and its current limitations14:15 | Closing remarks and creditsSoundtrack by The Underground Drive. All rights reserved. Listen more:https://music.apple.com/ca/artist/the-underground-drive/1571062779https://open.spotify.com/artist/4sCJG8TMQyTZ9FDd1JjJmRAbhijit Sinha (Content Generation), Mattheo Fakhouri (Producer), Mattea Abou Faiçal (Voice) and Jean-Paul Azzi (Post-production)

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related